Targeting B Cells and Antibody in Transplantation

B Lymphocytes Differentially Influence Acute and Chronic Allograft Rejection in Mice

(2011) D. J. DiLillo et al.   JOURNAL OF IMMUNOLOGY

Eculizumab, Bortezomib and Kidney Paired Donation Facilitate Transplantation of a Highly Sensitized Patient Without Vascular Access

(2010) B. E. Lonze et al.   AMERICAN JOURNAL OF TRANSPLANTATION

B Cells Help Alloreactive T Cells Differentiate Into Memory T Cells

(2010) Y.-H. Ng et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy of Induction Therapy with ATG and Intravenous Immunoglobulins in Patients with Low-Level Donor-Specific HLA-Antibodies

(2010) K. Bächler et al.   AMERICAN JOURNAL OF TRANSPLANTATION

An Unexpected Counter-Regulatory Role of IL-10 in B-Lymphocyte-Mediated Transplantation Tolerance

(2010) G. Zhao et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies

(2010) R. Sberro-Soussan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer

(2010) David J. DiLillo et al.   Annals of the New York Academy of Sciences

Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study

(2010) Mikkel Østergaard et al.   ARTHRITIS AND RHEUMATISM

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells

(2010) Y. Iwata et al.   BLOOD

Biologics in the treatment of systemic lupus erythematosus

(2010) Aisha Lateef et al.   CURRENT OPINION IN RHEUMATOLOGY

CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients

(2010) Paul A. Blair et al.   IMMUNITY

T cells and follicular dendritic cells in germinal center B-cell formation and selection

(2010) Carola G. Vinuesa et al.   IMMUNOLOGICAL REVIEWS

Identification of a B cell signature associated with renal transplant tolerance in humans

(2010) Kenneth A. Newell et al.   JOURNAL OF CLINICAL INVESTIGATION

Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection

(2010) Joanna Ashton-Chess et al.   KIDNEY INTERNATIONAL

Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype

(2010) Annaick Pallier et al.   KIDNEY INTERNATIONAL

B cells and transplantation tolerance

(2010) Allan D. Kirk et al.   Nature Reviews Nephrology

Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat

(2010) R. Vogelbacher et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Effect of the Proteasome Inhibitor Bortezomib on Humoral Immunity in Two Presensitized Renal Transplant Candidates

(2010) Markus Wahrmann et al.   TRANSPLANTATION

Clonal Deletion With Bortezomib Followed by Low or No Maintenance Immunosuppression in Renal Allograft Recipients

(2010) Hargovind L. Trivedi et al.   TRANSPLANTATION

B Cells and Plasma Cells in Coronaries of Chronically Rejected Cardiac Transplants

(2010) Jennifer R. Wehner et al.   TRANSPLANTATION

Combined Posttransplant Prophylactic IVIg/Anti-CD 20/Plasmapheresis in Kidney Recipients With Preformed Donor-Specific Antibodies: A Pilot Study

(2010) Alexandre Loupy et al.   TRANSPLANTATION

Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

(2010) R Carlin Walsh et al.   TRANSPLANTATION

Intravenous Immunoglobulins Promote Skin Allograft Acceptance by Triggering Functional Activation of CD4+Foxp3+ T cells

(2010) Thanyalak Tha-In et al.   TRANSPLANTATION

Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

(2010) Ashley A. Vo et al.   TRANSPLANTATION

The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation

(2010) Stuart M. Flechner et al.   TRANSPLANTATION

The yin and yang of B cells in graft rejection and tolerance

(2010) Valeriya Zarkhin et al.   Transplantation Reviews

B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation

(2010) Ronald F. Parsons et al.   Transplantation Reviews

Proteasome inhibition for antibody-mediated rejection

(2009) Jason J Everly et al.   Current Opinion in Organ Transplantation

Rituximab-induced vasculitis: A case report and review of the medical published work

(2009) Min Joo KIM et al.   JOURNAL OF DERMATOLOGY

CD19: a promising B cell target for rheumatoid arthritis

(2009) Thomas F. Tedder   Nature Reviews Rheumatology

B-Cell–Depleting Induction Therapy and Acute Cellular Rejection

(2009) Menna R. Clatworthy et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Use of Immunoglobulin Therapy for Patients Undergoing Solid Organ Transplantation: An Evidence-Based Practice Guideline

(2009) Nadine Shehata et al.   TRANSFUSION MEDICINE REVIEWS

Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation

(2009) Stanley C. Jordan et al.   TRANSPLANTATION

A Randomized, Doubleblind, Placebo-Controlled, Study of Single-Dose Rituximab as Induction in Renal Transplantation

(2009) Gunnar Tydén et al.   TRANSPLANTATION

Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection

(2009) Thomas Fehr et al.   TRANSPLANTATION

The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated Rejection

(2008) J. E. Locke et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Anti-Inflammatory Actions of Intravenous Immunoglobulin

(2008) Falk Nimmerjahn et al.   Annual Review of Immunology

CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy

(2008) P. Zhou et al.   BLOOD

BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact

(2008) J. L. Scholz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA